Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry; D002395:Catecholamines / Q000096:biosynthesis / Q000378:metabolism*; D002396:Catechols / Q000096:biosynthesis; D002421:Caudate Nucleus / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis; D007031:Hypothalamus / Q000378:metabolism*; D008297:Male; D009411:Nerve Endings / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000096:biosynthesis; D010640:Phenothiazines / Q000494:pharmacology*; D051381:Rats; D013378:Substantia Nigra / Q000378:metabolism*; D014316:Tritium; D014443:Tyrosine / Q000008:administration & dosage
D002395:Catecholamines; D002396:Catechols; D010640:Phenothiazines; D014316:Tritium; D014443:Tyrosine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine